Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance. Comment on the article by Samanta et al.
Mavrikakis
I
I
Mavrikakis
E
E
D018501:Antirheumatic Agents / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced*; D019983:Guideline Adherence; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D017410:Practice Guidelines as Topic
D018501:Antirheumatic Agents; D006886:Hydroxychloroquine